Amalia Paunovic
Papers
1
Total Citations
22
H-Index
1
About
Dr. Amalia Paunovic is a leading expert in assay development and high-throughput screening, with a primary focus on acoustic droplet ejection (ADE) technology for cell-based assays. Her seminal work, "Implementation and Challenges of Direct Acoustic Dosing into Cell-Based Assays" (2015, 22 citations), documents the transformative adoption of Labcyte Echo ADE technology at AstraZeneca since 2005, establishing it as the gold standard for compound dosing across global R&D. Dr. Paunovic’s contributions have been instrumental in overcoming key technical hurdles, such as ensuring cell viability and assay reproducibility during direct acoustic transfer, thereby enabling more efficient and precise drug screening. Her research has directly influenced the integration of ADE into routine pharmaceutical workflows, accelerating hit identification and lead optimization. With a career dedicated to bridging engineering and biology, Dr. Paunovic’s work continues to shape best practices in assay miniaturization and automation, making her a pivotal figure in modern drug discovery.
Research Focus
Key Achievements
Top Papers
- 1